Alzheimer's disease marker phospho-tau181 is not elevated in the first year after moderate-to-severe TBI.
Graham N., Zimmerman K., Heslegrave A.J., Keshavan A., Moro F., Abed-Maillard S., Bernini A., Dunet V., Garbero E., Nattino G. et al., 2024/03/13. Journal of neurology, neurosurgery, and psychiatry, 95 (4) pp. 356-359. Peer-reviewed.
ici le détail